Activo® Liquid - in vitro Trial Results
Is it possible to inhibit growth of antibiotic resistant pathogens (ESBL, MRSA) by the use of Activo® Liquid in vitro?
In this trial four ESBL producing E. coli, two MRSA and the nonresistant reference strains all isolated from farms were tested concerning their sensitivity against Activo® Liquid. Every bacteria strain (Concentration:1x104 Cfu/ml) had to undergo a bacterial inhibition assay in the appropriate medium at 37°C for 6-7 hours. (Laboratory: Vaxxinova, Münster)
In this trial Activo® Liquid, dependent on the concentrations used, could show bacteriostatic and bactericidal effects against Esbl-producing E. coli, MRSA, as well as the reference strains of both bacteria.
In case of questions or if you need further information, please do not hesitate to contact us: email@example.com. We are glad to assist you!
Author: Timo Rothstein, EW Nutrition Gmbh